The company operates cotton spinning mills in Gujarat, India, where it processes raw cotton into various grades of cotton yarn for sale to textile and garment manufacturers.
The company operates in a highly fragmented, commodity-based industry with no evidence of brand power or cost advantages, as reflected by volatile and often negative net margins. Low average ROCE of 5.7% confirms the lack of a durable competitive advantage or pricing power.
Management has prioritized debt reduction, successfully lowering outstanding debt by 32% in FY24, yet returns on reinvested capital remain poor. The decision to skip dividends is prudent given the low profitability and high debt-to-equity ratio of 1.17.
The investment collapsed as the business remained a commodity-trapped treadmill where capital was incinerated rather than compounded. Despite efforts to pay down debt, the company's reliance on related-party entities for core operations allowed for subtle value leakage that starved the balance sheet. A subsequent operational disruption, similar to the previous fire, exhausted the remaining liquidity, while the lack of pricing power meant inflationary costs could not be passed on. The frozen promoter accounts and regulatory filing delays were early warnings of a governance breakdown that eventually led to a total loss of investor confidence and a delisting threat.
RichFakir rates Angel Fibers Ltd's business quality as poor — 12/100 on our quality score (profitability, growth, balance-sheet strength and capital allocation). We assess its competitive moat as none.
On our model, Angel Fibers Ltd is trading about 71% below our estimate of fair value; we rate its price cheap. This is an educational estimate from public filings, not a recommendation.
RichFakir's educational verdict on Angel Fibers Ltd is: Avoid. We are steering clear of this one — the red flags below outweigh anything the price or numbers offer.
RichFakir's educational estimate of Angel Fibers Ltd's fair value is about ₹34 per share, derived from public filings. It's our estimate for research — not a price target or a recommendation to buy or sell.
View the full live analysis →